BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 33554142)

  • 1. Optimized protocol for gene editing in adipocytes using CRISPR-Cas9 technology.
    Qiu Y; Ding Q
    STAR Protoc; 2021 Mar; 2(1):100307. PubMed ID: 33554142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production and Validation of Lentiviral Vectors for CRISPR/Cas9 Delivery.
    Ryø LB; Thomsen EA; Mikkelsen JG
    Methods Mol Biol; 2019; 1961():93-109. PubMed ID: 30912042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heritable CRISPR-Cas9 editing of plant genomes using RNA virus vectors.
    Uranga M; Aragonés V; Daròs JA; Pasin F
    STAR Protoc; 2023 Mar; 4(1):102091. PubMed ID: 36853698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient Cas9 multiplex editing using unspaced sgRNA arrays engineering in a Potato virus X vector.
    Uranga M; Aragonés V; Selma S; Vázquez-Vilar M; Orzáez D; Daròs JA
    Plant J; 2021 Apr; 106(2):555-565. PubMed ID: 33484202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome Editing: CRISPR-Cas9.
    Hoof JB; Nødvig CS; Mortensen UH
    Methods Mol Biol; 2018; 1775():119-132. PubMed ID: 29876814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene Disruption Using CRISPR-Cas9 Technology.
    Hu N; Malek SN
    Methods Mol Biol; 2019; 1881():201-209. PubMed ID: 30350208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical-genetic CRISPR-Cas9 screens in human cells using a pathway-specific library.
    Hundley FV; Toczyski DP
    STAR Protoc; 2021 Sep; 2(3):100685. PubMed ID: 34382013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protocol for the saturation and multiplexing of genetic variants using CRISPR-Cas9.
    Sahu S; Sullivan T; Southon E; Caylor D; Geh J; Sharan SK
    STAR Protoc; 2023 Dec; 4(4):102702. PubMed ID: 37948185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR/Cas9 as a tool to dissect cancer mutations.
    Sayed S; Paszkowski-Rogacz M; Schmitt LT; Buchholz F
    Methods; 2019 Jul; 164-165():36-48. PubMed ID: 31078796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR deactivation in mammalian cells using photocleavable guide RNAs.
    Zou RS; Liu Y; Ha T
    STAR Protoc; 2021 Dec; 2(4):100909. PubMed ID: 34746867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid construction of multiple sgRNA vectors and knockout of the Arabidopsis IAA2 gene using the CRISPR/Cas9 genomic editing technology.
    Liu DY; Qiu T; Ding XH; Li M; Zhu MY; Wang JH
    Yi Chuan; 2016 Aug; 38(8):756-64. PubMed ID: 27531614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR/Cas9-Mediated Genome Editing for Huntington's Disease.
    Vachey G; Déglon N
    Methods Mol Biol; 2018; 1780():463-481. PubMed ID: 29856031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protocol for editing fibroblasts with in vitro transcribed Cas9 mRNA and profile off-target editing by optimized GUIDE-seq.
    Li Z; Reint G; Haapaniemi EM
    STAR Protoc; 2023 Dec; 4(4):102662. PubMed ID: 37889758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection of highly efficient sgRNAs for CRISPR/Cas9-based plant genome editing.
    Liang G; Zhang H; Lou D; Yu D
    Sci Rep; 2016 Feb; 6():21451. PubMed ID: 26891616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Single Transcript CRISPR-Cas9 System for Multiplex Genome Editing in Plants.
    Tang X; Zhong Z; Ren Q; Liu B; Zhang Y
    Methods Mol Biol; 2019; 1917():75-82. PubMed ID: 30610629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. sgRNA Sequence Motifs Blocking Efficient CRISPR/Cas9-Mediated Gene Editing.
    Graf R; Li X; Chu VT; Rajewsky K
    Cell Rep; 2019 Jan; 26(5):1098-1103.e3. PubMed ID: 30699341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and Assembly of CRISPR/Cas9 Lentiviral and rAAV Vectors for Targeted Genome Editing.
    Sandoval IM; Collier TJ; Manfredsson FP
    Methods Mol Biol; 2019; 1937():29-45. PubMed ID: 30706388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lentiviral Vectors for Delivery of Gene-Editing Systems Based on CRISPR/Cas: Current State and Perspectives.
    Dong W; Kantor B
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generating mutant
    Li HH; Li JC; Su MP; Liu KL; Chen CH
    STAR Protoc; 2021 Jun; 2(2):100432. PubMed ID: 33899015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimized protocols for efficient gene editing in mouse hepatocytes
    Chen Y; Ding Q
    STAR Protoc; 2022 Mar; 3(1):101062. PubMed ID: 35005644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.